Abstract
The effects of various agonists and antagonists of dopamine D1 and D2 receptors on lipopolysaccharide (LPS)-induced tumor necrosis factor-α (TNF-α) and nitric oxide (NO) production was investigated in mice. Pretreatment of animals with bromocryptine or quinpirole, agonists of dopamine D2 receptors caused a blunting of both the TNF-α and MO responses to LPS injected intraperitoneally. Sulpiride, an antagonist of dopamine D2 receptors, decreased the LPS-induced TNF-α plasma levels in a dose-dependent manner and inhibited the LPS-induced NO production by peritoneal macrophages. Bromocryptine or quinpirole blunted both the TNF-α and NO response to LPS. SCH-23390, an antagonist of dopamine D1 receptors did not alter LPS-induced TNF-α production, but inhibited LPS-induced NO production. These results indicate that while the D2 subtype of dopamine receptors is involved in the modulation of both LPS-induced TNF-α and NO production, dopamine D1 receptors only regulate the production of NO. Since several drugs possess effect on dopamine D2 receptors, the present observations may be of clinical relevance.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 143-147 |
| Number of pages | 5 |
| Journal | Immunology Letters |
| Volume | 49 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1996 |
| Externally published | Yes |
Keywords
- Bromocryptine
- Dopamine D receptors
- Dopamine D receptors
- Lipopolysaccharide-induced tumor necrosis factor-α
- SCH-23390
- Sulpiride
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS